Cart
sales@molnova.com
BET-BAY 002
CAS No. 1588521-78-1
BET-BAY 002( BET-BAY-002 )
Catalog No. M12268 CAS No. 1588521-78-1
BET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 312 | Get Quote |
|
| 50MG | 1341 | Get Quote |
|
| 100MG | 1791 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBET-BAY 002
-
NoteResearch use only, not for human use.
-
Brief DescriptionBET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.
-
DescriptionBET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.
-
In Vitro——
-
In Vivo——
-
SynonymsBET-BAY-002
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBromodomain
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1588521-78-1
-
Formula Weight403.8642
-
Molecular FormulaC22H18ClN5O
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC1=NN=C2N1C3=CC=CC=C3C(=CC2CC4=NN=C(O4)C)C5=CC=C(C=C5)Cl
-
Chemical Name4H-[1,2,4]Triazolo[4,3-a][1]benzazepine, 6-(4-chlorophenyl)-1-methyl-4-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-, (4R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ischemin
A cell permeable CBP bromodomain inhibitor with Kd of 19 uM.
-
BI 894999
BI 894999 is a novel potent, selective BET inhibitor with IC50 of 5 and 41 nM for BRD4-BD1 and BRD4-BD2 bromodomains, respectively.
-
(R)-(-)-JQ1 Enantiom...
(R)-(-)-JQ1 Enantiomer is the stereoisomer of (+)-JQ1, (+)-JQ-1 is a potent, specific BET bromodomain BRD4 inhibitor.
